Effect of risperidone on serum homocysteine levels in first-episode, drug-naïve patients with schizophrenia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuroscience Letters

• Publication date

  2017-05-22

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neulet.2017.04.025PMID 28419824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated homocysteine level in first-episode schizophrenia patients—the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse

  2014cited by this paper
• Magnetic Resonance Imaging in Studying Schizophrenia, Negative Symptoms, and the Glutamate System

  2014cited by this paper
• Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine

  2014cited by this paper
• Meta-analyses of Blood Homocysteine Levels for Gender and Genetic Association Studies of the MTHFR C677T Polymorphism in Schizophrenia

  2014cited by this paper
• The neurobiology and treatment of first-episode schizophrenia

  2014cited by this paper
• Homocysteine, Cobalamin and Folate Status and their Relations to Neurocognitive and Psychological Markers in Elderly in Northeasten of Iran

  2013cited by this paper
• Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy

  2013cited by this paper
• Association of the MTHFR gene with antipsychotic-induced metabolic abnormalities in patients with schizophrenia.

  2012cited by this paper
• The Oxidative Stress May be Induced by the Elevated Homocysteine in Schizophrenic Patients

  2012cited by this paper
• Association between MTHFR C677T and A1298C, and MTRR A66G polymorphisms and susceptibility to schizophrenia in a Syrian study cohort.

  2012cited by this paper
• Elevated Serum Levels of Homocysteine as an Early Prognostic Factor of Psychiatric Disorders in Children and Adolescents

  2012cited by this paper
• [Hyperhomocysteinemia and schizophrenia: case control study].

  2011cited by this paper
• The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis.

  2011cited by this paper
• Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics.

  2011cited by this paper
• Folate supplementation in schizophrenia: a possible role for MTHFR genotype.

  2011cited by this paper
• Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis.

  2011cited by this paper
• Role of fenofibrate alone and in combination with telmisartan on renal ischemia/reperfusion injury

  2010cited by this paper
• Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia.

  2010cited by this paper
• Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism.

  2010cited by this paper
• Rethinking schizophrenia

  2010cited by this paper
• Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents.

  2010cited by this paper
• Prospective, Open Study of Long-Acting Injected Risperidone versus Oral Antipsychotics in 88 Chronically Psychotic Patients

  2010cited by this paper
• Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population-based case-control study.

  2009cited by this paper
• The neurodevelopmental hypothesis of schizophrenia, revisited.

  2009cited by this paper
• One-carbon metabolism and schizophrenia: current challenges and future directions.

  2009cited by this paper
• Homocysteine Level in Schizophrenia Patients

  2009cited by this paper
• Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.

  2008cited by this paper
• Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia.

  2008cited by this paper
• Elevated prenatal homocysteine levels as a risk factor for schizophrenia.

  2007cited by this paper
• Plasma homocysteine, folate and B12 in chronic schizophrenia.

  2007cited by this paper
• A high-protein diet increases postprandial but not fasting plasma total homocysteine concentrations: a dietary controlled, crossover trial in healthy volunteers.

  2005cited by this paper
• Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia.

  2003cited by this paper
• Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage

  2002cited by this paper
• Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity

  2000cited by this paper
• Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor.

  1997cited by this paper

• Metabolic Mechanisms in Electroconvulsive Therapy for Schizophrenia: Role, Potential and Future Directions.

  2026cites this paper
• MTHFR and MTRR Polymorphisms Predict Sex-Dependent Psychotic Symptom Improvements, Not Metabolic Changes

  2026cites this paper
• Hyperhomocysteinemia in chronic schizophrenia: prevalence, clinical correlates, and paradoxical associations with symptom severity.

  2025cites this paper
• Homocysteine levels in first-episode patients with psychiatric disorders

  2024cites this paper
• Diverse avenues of research support the transmethylation theory of psychosis: implications for neuroprotection

  2024cites this paper
• Association of homocysteine with white matter dysconnectivity in schizophrenia

  2024cites this paper
• Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

  2023cites this paper
• Association of serum homocysteine levels with intestinal flora and cognitive function in schizophrenia.

  2023cites this paper
• Sulfur-containing amino acids and risk of schizophrenia.

  2023cites this paper
• Abnormalities in one-carbon metabolism in young patients with psychosis

  2023cites this paper
• Homocysteine Levels and Clinical Outcomes in Schizophrenia—A Pilot Randomized Controlled Trial

  2022cites this paper
• The Effects of Plasma Homocysteine Level on the Risk of Three Major Psychiatric Disorders: A Mendelian Randomization Study

  2022cites this paper
• Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia

  2022cites this paper
• Gender differences in associations of cognitive impairments with homocysteine in schizophrenia.

  2022cites this paper
• Relationship of serum homocysteine and vitamin D with positive, negative, and extrapyramidal symptoms in schizophrenia: a case–control study in Iran

  2022cites this paper
• Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?

  2021cites this paper
• Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia

  2020cites this paper
• Paroxetine combined with olanzapine in the treatment of schizophrenia

  2020cites this paper
• MTHFR Ala222Val polymorphism and clinical characteristics confer susceptibility to suicide attempt in chronic patients with schizophrenia

  2020cites this paper
• Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients

  2019cites this paper
• Alexithymia, suicide ideation, affective temperaments and homocysteine levels in drug naïve patients with post-traumatic stress disorder: an exploratory study in the everyday ‘real world’ clinical practice

  2019cites this paper